tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioAge Labs announces interim Phase 1 data for BGE-102
PremiumThe FlyBioAge Labs announces interim Phase 1 data for BGE-102
1M ago
BioAge Labs Advances Clinical Programs Amid Financial Progress
Premium
Company Announcements
BioAge Labs Advances Clinical Programs Amid Financial Progress
2M ago
BioAge Labs price target raised to $15 from $10 at Citi
Premium
The Fly
BioAge Labs price target raised to $15 from $10 at Citi
3M ago
BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102
PremiumThe FlyBioAge Labs announces first participant dosed in Phase 1 trial of BGE-102
5M ago
BioAge Labs Reports Q2 2025 Financial Results and Progress
Premium
Company Announcements
BioAge Labs Reports Q2 2025 Financial Results and Progress
5M ago
Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception
Premium
Ratings
Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception
5M ago
BioAge Labs expands APJ agonist pipeline with biologic candidates
PremiumThe FlyBioAge Labs expands APJ agonist pipeline with biologic candidates
7M ago
BioAge Labs completes IND-enabling studies for BGE-102
Premium
The Fly
BioAge Labs completes IND-enabling studies for BGE-102
8M ago
Cautious Outlook on BioAge Labs, Inc. Amid Program Setbacks and Financial Concerns
Premium
Ratings
Cautious Outlook on BioAge Labs, Inc. Amid Program Setbacks and Financial Concerns
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100